Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines
about
Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibitionProfile of neratinib and its potential in the treatment of breast cancerNovel therapeutic strategies for patients with triple-negative breast cancerBRCA1 pathway function in basal-like breast cancer cells.Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105Advances in small-molecule drug discovery for triple-negative breast cancer.PARP inhibitors are not all equal.Olaparib: first global approval.Concepts and Molecular Aspects in the Polypharmacology of PARP-1 Inhibitors.Differential Potential of Pharmacological PARP Inhibitors for Inhibiting Cell Proliferation and Inducing Apoptosis in Human Breast Cancer Cells.Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors.Enhancing the efficacy of radiation therapy: premises, promises, and practicality.FAM35A associates with REV7 and modulates DNA damage responses of normal and BRCA1-defective cells.
P2860
Q26851765-B45BEBE9-7076-4E8D-A1E9-12F65969EB99Q27012540-2E9D37C0-F8B8-4FB5-BCC0-EE19F8E55E21Q28067436-6C317825-A220-4011-8B9A-6887E3708B62Q34297981-EDF65EC1-F2B5-4E6F-A911-AB9B63E3918DQ35671356-44F76E8E-0873-467F-A381-79BA0F0D3EF6Q35818491-3D86ABBC-592B-4C01-B18D-05555BA8C7E0Q37589215-0E661852-0568-42E3-AF49-11C35356CE68Q38330356-A8483EEF-AB43-4C35-8434-BF752C0BDC64Q38596368-434BA3F7-681B-4001-967D-85D284E68580Q38874006-2EDE66E7-23E1-4F35-9430-3409BF25A2B4Q40883768-4281DE56-F36D-45A9-AE62-0B5DB6A0A983Q42545565-DE8A107C-8F6C-45F4-90E5-5EF15A42A4FCQ55394676-5D873EF1-F801-4EB0-9887-A232D53DC334
P2860
Comparative antiproliferative effects of iniparib and olaparib on a panel of triple-negative and non-triple-negative breast cancer cell lines
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative antiproliferative ...... ative breast cancer cell lines
@en
Comparative antiproliferative ...... tive breast cancer cell lines.
@nl
type
label
Comparative antiproliferative ...... ative breast cancer cell lines
@en
Comparative antiproliferative ...... tive breast cancer cell lines.
@nl
prefLabel
Comparative antiproliferative ...... ative breast cancer cell lines
@en
Comparative antiproliferative ...... tive breast cancer cell lines.
@nl
P2093
P2860
P50
P356
P1476
Comparative antiproliferative ...... ative breast cancer cell lines
@en
P2093
Aisling Pierce
John Crown
Maura Cotter
Michael J Duffy
Patricia M McGowan
P2860
P304
P356
10.4161/CBT.24349
P577
2013-06-01T00:00:00Z